- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Ochsner Cancer Institute | Strategic Alliance Partners
For over 70 years, Ochsner has been dedicated to cancer research and new cancer treatment development, bringing innovations to the fight against cancer— including more clinical trials than anywhere else in the Gulf South region. Ochsner provides cancer services for adult and pediatric cancer patients and their families from diagnosis through recovery, including the most complex and difficult to treat cancers.
Latest from Ochsner Cancer Institute
Ochsner Health Wins Innovator Award Funds for Connected MOM
July 12, 2024
Article
The HHS competition evaluated the effectiveness of Ochsner Connected MOM in increasing blood pressure monitoring during pregnancy and the postpartum period.
Nihilism Remains a Barrier to Effective Treatment Delivery in Pancreatic Cancer
May 10, 2022
Article
Jonathan Mizrahi, MD, discusses updates from the meeting in pancreatic cancer and hepatocellular carcinoma, the growing role of immunotherapy in GI cancer, and the ‘watch and wait’ protocol seen in rectal cancer
Expanded Combinations, Novel Agents, and MRD-Informed Trials Transform Myeloma Paradigm
February 11, 2022
Article
Laura Finn, MD, provides a deep dive into pivotal data with combinations and novel agents that have changed the paradigm for patients with newly diagnosed, early relapsed, and late relapsed multiple myeloma.
Dr. Cole on Next Steps With Tucatinib in HER2+ Breast Cancer
January 19, 2022
Video
John Cole, MD, discusses the next steps with tucatinib in HER2-positive breast cancer.
Dr. Finn on the Utility of Belantamab Mafodotin in Late Relapsed Multiple Myeloma
January 17, 2022
Video
Laura Finn, MD, discusses the utility of belantamab mafodotin-blmf in late relapsed multiple myeloma.
New and Updated Findings Showcase a Shift With Immunotherapy Across Melanoma
August 16, 2021
Article
Data that emerged from the 2021 ASCO Annual Meeting represent potential paradigm shifts for patients with advanced melanoma.
The Gayle and Tom Benson Cancer Center Celebrates Expansion with Grand Re-Opening
September 29, 2020
Article
The Gayle and Tom Benson Cancer Center at Ochsner Medical Center is celebrating its grand re-opening today after the completion of a $56 million expansion, which began in 2018.
Remote Monitoring Enhances Care for Patients With Head and Neck Cancer
February 21, 2020
Article
If clinicians can identify complications earlier and take appropriate prophylactic or therapeutic measures, treatment plan adherence and outcomes may be improved for patients with head and neck cancer.
Ochsner and Statewide Partners Awarded $13.6 Million NCI Grant
September 16, 2019
Article
Ochsner Cancer Institute (Ochsner), along with its Gulf South NCI Community Oncology Research Program (NCORP) partners, has been awarded a $13.6 million grant by the National Cancer Institute to expand the successful statewide clinical trials network with a special emphasis on minority and underserved cancer patients.
Benson Cancer Center Earns National Re-Accreditation with Commendation from the Commission on Cancer of the American College of Surgeons
August 23, 2019
Article
The Gayle and Tom Benson Cancer Center at Ochsner Medical Center (Benson Cancer Center) has again been granted Three-Year Accreditation with Commendation from The Commission on Cancer, a quality program of the American College of Surgeons.